(Q34982117)

5 August 2017

1 reference

title

Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures (English)

1 reference

5 August 2017

1 reference

1 reference

Paris Roach

1

1 reference

PubMed ID

12403642

5 August 2017

James R Woodworth

series ordinal

2

1 reference

5 August 2017

1 January 2002

1 reference

Clinical Pharmacokinetics

5 August 2017

1 reference

5 August 2017

41

1 reference

5 August 2017

13

1 reference

5 August 2017

1043-1057

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200241130-00003

5 August 2017

0 references

cites work

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

1 reference

12 December 2020

Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

1 reference

12 December 2020

The human insulin analogue insulin lispro

1 reference

12 December 2020

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Efficacy of a premixed semisynthetic human insulin regimen

1 reference

12 December 2020

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

12 December 2020

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Monomeric insulins and their experimental and clinical implications

1 reference

12 December 2020

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

1 reference

12 December 2020

Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control

1 reference

12 December 2020

Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients

1 reference

12 December 2020

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.

1 reference

12 December 2020

Insulin secretion in diabetes mellitus

1 reference

12 December 2020

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

12 December 2020

Altering the association properties of insulin by amino acid replacement

1 reference

12 December 2020

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

1 reference

12 December 2020

A comparison of premixed with patient-mixed insulins

1 reference

12 December 2020

Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM

1 reference

12 December 2020

Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens

1 reference

12 December 2020

Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin

1 reference

12 December 2020

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group

1 reference

12 December 2020

10.2165/00003088-200241130-00003

Identifiers

DOI

1 reference

PubMed ID

12403642

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12403642